Researchers at the Pacific Northwest Research Institute (PNRI) in Seattle and the University of Exeter in the U.K. have developed a new method of screening babies and adults for future risk of Type 1 diabetes (T1D). Called the T1D GRS2, this new method will be much more effective than current methods. It takes into account detailed genetic information known to increase the chances of Type 1 diabetes and could make prediction of Type 1 diabetes among all children much more affordable in public health settings.
Being able to identify who will develop Type 1 diabetes before its onset could help parents and doctors identify the condition before it becomes severe. Furthermore, this research could help researchers develop effective treatments to prevent the disease. According to the American Diabetes Association, 40,000 people are newly diagnosed with Type 1 diabetes each year in the U.S.
